Caricamento...
Early experience of Sacubitril–Valsartan in heart failure with reduced ejection fraction in real‐world clinical setting
AIMS: Sacubitril/Valsartan (Sac/Val) was proven more effective than enalapril for symptomatic patients with heart failure (HF) with reduced ejection fraction (HFrEF). This study aimed to investigate eligibility, titration, and tolerability for Sac/Val in a real‐world clinical setting. METHODS AND RE...
Salvato in:
| Pubblicato in: | ESC Heart Fail |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261574/ https://ncbi.nlm.nih.gov/pubmed/32030899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12644 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|